Evidence map›Paper›PMID 38952557›Full record

ArticleFrontiers in oncology2024

Nomenclature of the symptoms of head and neck cancer: a systematic scoping review.

Paula T Bradley, Ying Ki Lee, Abigail Albutt, John Hardman, Ian Kellar, Chinasa Odo, Rebecca Randell, Nikki Rousseau, Theofano Tikka, Joanne M Patterson and 1 more

Abstract readScoping Review
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Head and neck squamous cell carcinoma: current and emerging therapeutic strategies.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Paula T BradleyPopulation Health, Newcastle University, Newcastle upon Tyne, United Kingdom.
Ying Ki LeeDepartment of Otolaryngology, Guy's and St Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom.
Abigail AlbuttFaculty of Medicine and Health, University of Leeds, Leeds, United Kingdom.
John HardmanDepartment of Otolaryngology, Barts Health NHS Trust, London, United Kingdom.
Ian KellarDepartment of Psychology, The University of Sheffield, Sheffield, United Kingdom.
Chinasa OdoFaculty of Health Studies, University of Bradford, Bradford, United Kingdom.
Rebecca RandellFaculty of Health Studies, University of Bradford, Bradford, United Kingdom.
Nikki RousseauFaculty of Medicine and Health, University of Leeds, Leeds, United Kingdom.
Theofano TikkaDepartment of Otolaryngology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Joanne M PattersonSchool of Allied Health Professions & Nursing, Institute of Population Health / Liverpool Head and Neck Centre, University of Liverpool, Liverpool, United Kingdom.
Vinidh PaleriHead and Neck Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Evolution of a patient-reported symptom-based risk stratification system to redesign the suspected head and neck cancer (HNC) referral pathway (EVEREST-HN) will use a broad and open approach to the nomenclature and symptomatology. It aims to capture and utilise the patient reported symptoms in a modern way to identify patients' clinical problems more effectively and risk stratify the patient. Method: The review followed the PRISMA checklist for scoping reviews. A search strategy was carried out using Medline, Embase and Web of Science between January 1st 2012 and October 31st 2023. All titles, abstracts and full paper were screened for eligibility, papers were assessed for inclusion using predetermined criteria. Data was extracted pertaining to the aims, type of study, cancer type, numbers of patients included and symptoms, presenting complaints or signs and symptoms. Results: There were 9,331 publications identified in the searches, following title screening 350 abstracts were reviewed for inclusion and 120 were considered for eligibility for the review. 48 publications met the eligibility criteria and were included in the final review. Data from almost 11,000 HNC patients was included. Twenty-one of the publications were from the UK, most were retrospective examination of patient records. Data was extracted and charted according to the anatomical area of the head and neck where the symptoms are subjectively and objectively found, and presented according to lay terms for symptoms, clinical terms for symptoms and the language of objective clinical findings. Discussion: Symptoms of HNC are common presenting complaints, interpreting these along with clinical history, examination and risk factors will inform a clinician's decision to refer as suspected cancer. UK Head and Neck specialists believe a different way of triaging the referrals is needed to assess the clinical risk of an undiagnosed HNC. EVEREST-HN aims to achieve this using the patient history of their symptoms. This review has highlighted issues in terms of what is considered a symptom, a presenting complaint and a clinical finding or sign.

Indexed as

gatekeeperhead and neck cancerreferralrisk assessment scoring systemsymptom assessment

Identifiers

PMID38952557
PMCPMC11216301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.